Why the study?
Does recombinant hirudin reduce neointimal growth after arterial injury in different animal models?
Population
Four animal models of arterial injury: carotid artery balloon injury in rats, rabbits, and…
Design
Preclinical
Follow-up
2 to 4 weeks
Authors
Loading...
Species differences in r-hirudin response warrant caution in translation; leaves open optimal regimens and multi-model testing for antirestenotic therapies.
Does recombinant hirudin reduce neointimal growth after arterial injury in different animal models?
The efficacy of thrombin inhibition for reducing neointimal growth after arterial injury varies significantly across species, highlighting the need for testing antirestenotic therapies in multiple animal models.
Gerdes et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: